Operating
ResMed·Cash Flow Statement·17 metrics
Breakdown
| Metric | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 | Q3 '26 |
|---|---|---|---|---|---|---|---|---|
| Net cash from operating activities | $440.1M | $325.5M | $308.6M | $578.7M | $538.8M | $457.3M | $339.7M | $554.1M |
| Net income | $292.2M | $311.4M | $344.6M | $365M | $379.7M | $348.5M | $392.6M | $398.7M |
| Change in accounts payable | $122M | -$25.4M | $4.2M | $63.1M | $49.1M | $7.6M | $10.6M | $103.9M |
| Depreciation and amortization | $43.7M | $44.7M | $46.4M | $43.7M | $63.6M | $47.7M | $49.9M | $59M |
| Change in other assets | $16.2M | $123K | $43.6M | -$79.4M | -$47M | -$2.3M | $106.4M | $48.3M |
| Increase (Decrease) in Prepaid Expense and Other Assets | $16.2M | $123K | $43.6M | -$79.4M | -$47M | -$2.3M | $106.4M | $48.3M |
| Stock-based compensation | $21.4M | $20.2M | $22.6M | $24.1M | $24.8M | $21.2M | $28.9M | $26.8M |
| Change in accounts receivable | $57.5M | -$36.4M | $67.9M | $40M | $5.2M | -$30M | $72.7M | $16.9M |
| Change in inventories | -$8.9M | $70.3M | $7.6M | — | $32.1M | $14.7M | -$26.1M | -$12.5M |
| Net gains (losses) on investments | -$15.5M | -$680K | -$1.4M | -$5.6M | -$2.5M | -$6.2M | — | -$10.1M |
| Unrealized gain (loss) on debt and equity securities, net | -$15.5M | -$680K | -$1.4M | -$5.6M | -$2.5M | -$6.2M | — | -$10.1M |
| Non-cash operating lease expense | $11.1M | $9M | $9.5M | $8.2M | $10.7M | $10M | $12.4M | $10.1M |
| Operating lease right-of-use asset amortization | $11.1M | $9M | $9.5M | $8.2M | $10.7M | $10M | $12.4M | $10.1M |
| Equity in earnings (losses) of equity method investees | — | $963K | $1.1M | $335K | $1.3M | $1.5M | $1.5M | $1.7M |
| Distributions from equity method investments | -$462K | $911K | $911K | $911K | $911K | — | — | — |
| Income Loss From Equity Method Investments Net Of Dividends Or Distributions | -$462K | $911K | $911K | $911K | $911K | — | — | — |
| Insurance Recoveries | $0 | $0 | $0 | $0 | $0 | — | — | — |